Back to search
FDAFDA · Food and drugs·Recall number H-0447-2025

Lithium Orotate 2.5; 60 vegetarian capsules, Dietary Supplement; Distributed by Mecene LLC. 447 Sutter St., Suite 405, San Fransisco, CA 94108 2.5 mg UPC#: X002T4OPLL 10 mg UPC#: X0031AXVE9

Published August 20, 2025 · Recall initiated: June 24, 2025

Summary

FDA records food Class III recall H-0447-2025, published August 20, 2025 and initiated June 24, 2025. Recalling firm: GMP Laboratories of America Inc; Status: Terminated; Reported quantity: ~185,482 capsules; Lot: 2.5mg Lot #: 21822 Expire date: 09/2026 10mg Lot#: 21108; 22649 Expire date: 10/2025; 01/2028. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Downstream recall of a dietary supplement ingredient that was manufactured out of specifications.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
GMP Laboratories of America Inc
Distributor
Distribution was to a single customer who received product in California and Oklahoma.
Lot
2.5mg Lot #: 21822 Expire date: 09/2026 10mg Lot#: 21108; 22649 Expire date: 10/2025; 01/2028
Risk classification
Class III
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was Lithium Orotate 2.5; 60 vegetarian capsules, Dietary Supplement; Distributed by Mecene LLC. 447 Sutter St., Suite 405, San Fransisco, CA 94108 2.5 mg UPC#: X002T4OPLL 10 mg UPC#: X0031AXVE9 recalled?

Yes. FDA published recall H-0447-2025 on August 20, 2025. Reported hazard: Downstream recall of a dietary supplement ingredient that was manufactured out of specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone